Until recently, the only drugs with evidence of benefit on DKD were Angiotensin-Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARBs) because of their effect of albuminuria reduction or regression and slowing of CKD progression. This evidence concerns the gene ACE and chronic kidney disease.